Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity.
暂无分享,去创建一个
M. Björkholm | M. Hou | A. Gruber | D Xu | M Hou | M Björkholm | A Gruber | D. Xu | Dawei Xu
[1] G. Roos,et al. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. , 1996, Blood.
[2] J. Mulé,et al. A rapid and quantitative assay to estimate gene transfer into retrovirally transduced hematopoietic stem/progenitor cells using a 96-well format PCR and fluorescent detection system universal for MMLV-based proviruses. , 1996, Human gene therapy.
[3] M. Spitz,et al. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer , 1999, British Journal of Cancer.
[4] E. Dmitrovsky,et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. , 1996, Cancer research.
[5] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[6] C. Greider,et al. Telomerase regulation during entry into the cell cycle in normal human T cells. , 1996, Molecular biology of the cell.
[7] J. Shay,et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. , 1995, Journal of immunology.
[8] C. Harley,et al. Telomerase, cell immortality, and cancer. , 1994, Cold Spring Harbor symposia on quantitative biology.
[9] A. Sartorelli,et al. Differentiation of immortal cells inhibits telomerase activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Weil,et al. Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[11] C. R. Connell,et al. Allelic discrimination by nick-translation PCR with fluorogenic probes. , 1993, Nucleic acids research.
[12] P. Pisa,et al. Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia , 1998, British journal of haematology.
[13] M. Björkholm,et al. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms , 1999, British Journal of Cancer.
[14] R. Badolato,et al. Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment , 1998, British Journal of Haematology.
[15] J. Shay,et al. Regulation of telomerase activity in immortal cell lines , 1996, Molecular and cellular biology.
[16] K. Riabowol,et al. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. , 1996, Cancer research.
[17] J. Shay,et al. Lack of cell cycle regulation of telomerase activity in human cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[18] P. Pisa,et al. Supression of telomerase activity in HL60 cells after treatment with differentiating agents. , 1996, Leukemia.
[19] M. Erlanson,et al. Telomerase activity in Hodgkin's disease. , 1998, Blood.
[20] Nam W. Kim,et al. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) , 1997, Nucleic Acids Res..
[21] S. Gallinger,et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. , 1995, Cancer research.